Oncology Institute Inc’s filing revealed that its Chief Executive Officer Virnich Daniel acquired Company’s shares for reported $23584.0 on Mar 26 ’25. In the deal valued at $1.04 per share,22,640 shares were bought. As a result of this transaction, Virnich Daniel now holds 724,363 shares worth roughly $0.83 million.
Then, Podnos Yale bought 9,056 shares, generating $9,434 in total proceeds. Upon buying the shares at $1.04, the Chief Medical Officer now owns 79,049 shares.
Before that, Pacala Mark L bought 90,562 shares. Oncology Institute Inc shares valued at $94,338 were divested by the Director at a price of $1.04 per share. As a result of the transaction, Pacala Mark L now holds 224,971 shares, worth roughly $0.26 million.
A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Jefferies began covering TOI with “Buy” recommendation on August 15, 2022.
Price Performance Review of TOI
On Monday, Oncology Institute Inc [NASDAQ:TOI] saw its stock unchanged to $1.14. Over the last five days, the stock has lost -8.06%. Oncology Institute Inc shares have risen nearly 268.93% since the year began. Nevertheless, the stocks have fallen -38.04% over the past one year. While a 52-week high of $1.63 was reached on 03/25/25, a 52-week low of $0.13 was recorded on 01/10/25. SMA at 50 days reached $0.8607, while 200 days put it at $0.4745.
Levels Of Support And Resistance For TOI Stock
The 24-hour chart illustrates a support level at 1.0467, which if violated will result in even more drops to 0.9533. On the upside, there is a resistance level at 1.2667. A further resistance level may holdings at 1.3933. The Relative Strength Index (RSI) on the 14-day chart is 64.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1682, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.14%. Stochastics %K at 63.28% indicates the stock is a holding.
How much short interest is there in Oncology Institute Inc?
A steep rise in short interest was recorded in Oncology Institute Inc stocks on 2025-03-14, growing by 0.17 million shares to a total of 1.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 0.93 million shares. There was a rise of 15.36%, which implies that there is a positive sentiment for the stock.
